Effects of a partnership‐based, needs‐tailored self‐management support intervention for post‐treatment breast cancer survivors: A randomized controlled trial. Issue 3 (27th September 2021)

• Record Type: Journal Article
• Authors: Kim, Soo Hyun; Choe, Yu Hyeon; Cho, Young Up; Park, Seho; Lee, Moon Hee
• Is Part Of: Psycho-oncology. Volume 31:Issue 3(2022)
• Page Start: 460
• Page End: 469
• Publication Date: 2021-09-27
• Subjects: breast cancer survivors -- health‐related quality of life -- oncology -- psycho‐oncology -- randomized controlled trial -- self‐efficacy -- self‐management; Cancer -- Psychological aspects -- Periodicals; Cancer -- Social aspects -- Periodicals; Neoplasms -- psychology -- Periodicals; 616.9940019
• DOI: 10.1002/pon.5828
• Languages: English
• ISSNs: 1057-9249

Abstract

Abstract: Objective: To examine the effectiveness of partnErship‐based, needs‐tailored self‐Management support Program fOr Women with breast cancER (EMPOWER), a partnership‐based, needs‐tailored, self‐management (SM) support intervention designed to empower post‐treatment breast cancer survivors (BCSs) and ultimately improve their health outcomes. Methods: This multi‐center, two‐armed, randomized controlled trial comprised 94 female BCSs who had completed primary cancer treatment in South Korea. Participants were randomly assigned (1:1) to the intervention group or the wait‐list control group. The intervention group received a 7‐week EMPOWER intervention via telephone counseling. The primary outcome was empowerment. Secondary outcomes included self‐efficacy for post‐treatment SM behaviors, mental adjustment, anxiety, depression, and health‐related quality of life. Data were collected via a self‐reported questionnaire at baseline (T0) and at 8 (T1) and 20 weeks (T2) of follow‐up. Linear mixed models were used to assess group differences over time. Effective sizes were calculated using Cohen's d . Results: Retention rates were excellent (95.7% at T1; 94.7% at T2). Linear mixed model analyses revealed that the EMPOWER group showed significantly improved empowerment (mean difference 2.24, 95% CI = 0.18 to 4.29; p = 0.016) and general health perception (mean difference 3.68, 95% CI = 0.67 to 6.72; p = 0.037) compared with the control group. Time point analysis showed that several secondary outcomes significantly improved at T1, but the effects were not sustained. Conclusion: EMPOWER was effective in improving empowerment and general health perception among post‐treatment BCS. Further studies are needed to determine the effectiveness of the EMPOWER intervention in other cancer populations.